{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:26:25Z","timestamp":1790767585148,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010113","name":"Wilhelm and Else Stockmanns Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010113","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010119","name":"Stiftelsen Dorothea Olivia Karl Walter och Jarl Walter Perkl\u00e9ns minne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010116","name":"Medicinska Underst\u00f6dsf\u00f6reningen Liv och H\u00e4lsa rf","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015736","name":"Folkh\u00e4lsan Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013500","name":"Diabetes Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"HUS Helsinki University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jdiacomp.2026.109331","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:55:16Z","timestamp":1776927316000},"page":"109331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between chronic low-grade inflammation and metabolic syndrome and their impact on the risk of coronary artery disease in type 1 diabetes"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5880-3082","authenticated-orcid":false,"given":"Johanna M.","family":"Blomqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5205-4498","authenticated-orcid":false,"given":"Marika I.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3568-9779","authenticated-orcid":false,"given":"Valma","family":"Harjutsalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5844-9925","authenticated-orcid":false,"given":"Patrik","family":"Smidtslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-6954","authenticated-orcid":false,"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3999-0390","authenticated-orcid":false,"given":"Lena M.","family":"Thorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2026.109331_bb0005","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","article-title":"High risk of cardiovascular disease in patients with type 1 diabetes in the U.K","volume":"29","author":"Soedamah-Muthu","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0010","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2337\/diacare.28.8.2019","article-title":"Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study)","volume":"28","author":"Thorn","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0015","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2337\/dc08-2022","article-title":"Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes","volume":"32","author":"Thorn","year":"2009","journal-title":"Diabetes Care."},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12933-024-02234-x","article-title":"Insulin sensitivity estimates and their longitudinal association with coronary artery disease in type 1 diabetes. Does it matter?","volume":"23","author":"Mutter","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0025","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1210\/endrev\/bnae032","article-title":"Insulin resistance in type 1 diabetes: pathophysiological, clinical, and therapeutic relevance","volume":"46","author":"Apostolopoulou","year":"2025","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdiacomp.2006.10.005","article-title":"The metabolic syndrome in type 1 diabetes: does it exist and does it matter?","volume":"22","author":"McGill","year":"2008","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinchem\/43.1.52","article-title":"Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications","volume":"43","author":"Macy","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0055","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.jdiacomp.2026.109331_bb0060","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24143","article-title":"Multiplex analysis of inflammatory proteins associated with risk of coronary artery disease in type-1 diabetes patients","volume":"47","author":"Beatty","year":"2024","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0075","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1136\/bmj.294.6588.1651","article-title":"Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus","volume":"294","author":"Borch-Johnsen","year":"1987","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0080","doi-asserted-by":"crossref","first-page":"e2032","DOI":"10.1210\/clinem\/dgaa015","article-title":"Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry","volume":"105","author":"Shah","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0085","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s00125-003-1194-5","article-title":"Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients","volume":"46","author":"Saraheimo","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0090","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0100","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0105","first-page":"e15431","article-title":"Lessons learned from the FinnDiane study: epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes","author":"Jansson Sigfrids","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2296-4-18","article-title":"Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials","volume":"4","author":"Edwards","year":"2003","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0115","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/0300060514541829","article-title":"Metabolic syndrome, adiponectin and proinflammatory status in patients with type 1 diabetes mellitus","volume":"42","author":"Timar","year":"2014","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1684\/ecn.2020.0459","article-title":"Absence of increased liver-related inflammatory markers in type 1 diabetes with metabolic syndrome: a nested case-control study from Brazil","volume":"31","author":"Barros","year":"2020","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0125","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.3390\/biomedicines11123269","article-title":"Association of endotoxemia with low-grade inflammation, metabolic syndrome and distinct response to lipopolysaccharide in type 1 diabetes","volume":"11","author":"Fedulovs","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111804","article-title":"Sex and age differences in the association between high sensitivity C-reactive protein and all-cause mortality: a 12-year prospective cohort study","volume":"211","author":"Bafei","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12020-012-9743-7","article-title":"C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study","volume":"43","author":"Yang","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","article-title":"Albuminuria reflects widespread vascular damage: the Steno hypothesis","volume":"32","author":"Deckert","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00592-016-0949-7","article-title":"Cardiovascular complications of type 1 diabetes: update on the renal link","volume":"54","author":"Orchard","year":"2017","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jdiacomp.2026.109331_bb0155","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0160","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1161\/CIRCULATIONAHA.118.037454","article-title":"Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus","volume":"139","author":"Rawshani","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0165","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMra2311526","article-title":"Prevention of cardiovascular disease in type 1 diabetes","volume":"390","author":"Manrique-Acevedo","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12933-024-02207-0","article-title":"Contributions of elevated CRP, hyperglycaemia, and type 2 diabetes to cardiovascular risk in the general population: observational and Mendelian randomization studies","volume":"23","author":"Rolver","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/605810","article-title":"C-reactive protein: clinical and epidemiological perspectives","volume":"2014","author":"Salazar","year":"2014","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.jdiacomp.2026.109331_bb0180","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults","volume":"56","author":"Greenland","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:17:10Z","timestamp":1778797030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872726000760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1056872726000760"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109331","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between chronic low-grade inflammation and metabolic syndrome and their impact on the risk of coronary artery disease in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109331"}}